Ovarian tumours: Difference between revisions
Jump to navigation
Jump to search
→Sertoli-Leydig tumour: re-work |
|||
| Line 561: | Line 561: | ||
*Alpha-inhibin +ve (90%+).<ref name=pmid16810055/> | *Alpha-inhibin +ve (90%+).<ref name=pmid16810055/> | ||
==Sertoli-Leydig tumour== | ==Sertoli-Leydig cell tumour== | ||
*[[AKA]] ''androblastoma''. | *[[AKA]] ''androblastoma''. | ||
===General=== | ===General=== | ||